SCHEMBL29952603

SCHEMBL29952603

O=Cc1ccc2c(c1)CNC2=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.50
CA9 Q16790 1/20 0.50
PRF1 P14222 5/20 0.49
GRM5 P41594 4/20 0.49
GSK3B P49841 3/20 0.46
CLK4 Q9HAZ1 2/20 0.46
NTRK1 P04629 2/20 0.46
FLT3 P36888 2/20 0.46
DAPK3 O43293 1/20 0.46
PIM1 P11309 1/20 0.46
ROCK1 Q13464 1/20 0.46
MKNK1 Q9BUB5 2/20 0.42
PRKCI P41743 1/20 0.41
NTRK2 Q16620 2/20 0.41
TYRO3 Q06418 1/20 0.41
DYRK1B Q9Y463 1/20 0.41
JAK2 O60674 1/20 0.40
MET P08581 1/20 0.40
FGFR1 P11362 1/20 0.40
PRKACA P17612 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4610013 1.00 CA12 (0.50) CA12CA9PRF1GRM5GSK3B
SCHEMBL2014718 0.86 PRF1 (0.61) CA12CA9PRF1GRM5GSK3B
SCHEMBL29950887 0.85 CLK4 (0.53) CA12CA9PRF1GRM5GSK3B
SCHEMBL26119392 0.85 CLK4 (0.53) CA12CA9PRF1GRM5GSK3B
SCHEMBL28697772 0.84 PRF1 (0.51) CA12CA9PRF1GRM5GSK3B
SCHEMBL2017969 0.82 PRF1 (0.64) CA12CA9PRF1GRM5GSK3B
SCHEMBL3946742 0.82 PARP10 (0.60) GRM5PARP1
SCHEMBL25042822 0.80 PRF1 (0.45) CA12CA9PRF1GRM5GSK3B
SCHEMBL618639 0.73 CA12 (0.53) CA12CA9PRF1GRM5GSK3B
SCHEMBL164795 0.73 GRM5 (0.68) CA12CA9PRF1GRM5GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4665332-A2 CYCLIN DEPENDENT KINASE DEGRADERS AND METHODS OF USE THEREOF Differentiated Therapeutics Inc (US) 2025-12-24 EP disclosed
WO-2024173412-A2 CYCLIN DEPENDENT KINASE DEGRADERS AND METHODS OF USE THEREOF DIFFERENTIATED THERAPEUTICS, INC. (US) 2024-08-22 WO disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed